BioCentury | Feb 9, 2009
Company News

Biotecnol S.A., INSERM, Hopitaux Universitaires de Strasbourg, Universite Louis Pasteur deal

...S.A. , Oeiras, Portugal INSERM , Paris, France Hopitaux Universitaires de Strasbourg , Strasbourg, France Universite Louis Pasteur...
BioCentury | Oct 1, 2007
Company News

NexGenix, Universite Louis Pasteur, Centre National de la Recherche Scientifique deal

...of the compounds. Further terms were not disclosed. NexGenix Pharmaceuticals Inc. , New York, N.Y. Universite Louis Pasteur...
BioCentury | Sep 8, 2003
Emerging Company Profile

Corporate Profile

Faust Pharmaceuticals S.A. Illkirch, France Technology: Presynaptic neurotransmitter modulation Disease focus: Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), neuropathies and amy-otrophic lateral sclerosis (ALS) Clinical status: Preclinical Founded: 2001 by Maurice Israel, Pierre...
BioCentury | Apr 21, 2003
Emerging Company Profile

Corporate Profile

CareX S.A. Strasbourg, France Technology: Nuclear receptor research Disease focus: Metabolic diseases Clinical status: Preclinical Founded: March 2002 by Pierre Chambon and Johan Auwerx Corporate partners: NA University collaborators: Institut de Génétique et de Biologie...
BioCentury | Apr 9, 2001
Strategy

The original Gencell gang

The original Gencell gang Applied Immune Sciences Darwin Molecular Group Généthon Genetix Pharmaceuticals Genopoïetic Institut Gustave Roussy Institut Pasteur Lille Introgen Therapeutics Lawrence Berkeley Laboratory Human Gene Center Pasteur Merieux Connaught Transgène Université Louis Pasteur...
BioCentury | Mar 11, 1996
Company News

Universite Louis Pasteur other research news

...of repeats in the FA mutation doesn't correlate with disease severity or age of onset. Universite Louis Pasteur...
BioCentury | Nov 21, 1994
Strategy

How RPR's network creates a complete tool kit

How RPR's network creates a complete tool kit Rhône-Poulenc Rorer Inc.'s gene therapy consortium is designed to create a complete "toolbox" that will give the company the critical mass of technology that currently is dispersed...
Items per page:
1 - 7 of 7
BioCentury | Feb 9, 2009
Company News

Biotecnol S.A., INSERM, Hopitaux Universitaires de Strasbourg, Universite Louis Pasteur deal

...S.A. , Oeiras, Portugal INSERM , Paris, France Hopitaux Universitaires de Strasbourg , Strasbourg, France Universite Louis Pasteur...
BioCentury | Oct 1, 2007
Company News

NexGenix, Universite Louis Pasteur, Centre National de la Recherche Scientifique deal

...of the compounds. Further terms were not disclosed. NexGenix Pharmaceuticals Inc. , New York, N.Y. Universite Louis Pasteur...
BioCentury | Sep 8, 2003
Emerging Company Profile

Corporate Profile

Faust Pharmaceuticals S.A. Illkirch, France Technology: Presynaptic neurotransmitter modulation Disease focus: Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), neuropathies and amy-otrophic lateral sclerosis (ALS) Clinical status: Preclinical Founded: 2001 by Maurice Israel, Pierre...
BioCentury | Apr 21, 2003
Emerging Company Profile

Corporate Profile

CareX S.A. Strasbourg, France Technology: Nuclear receptor research Disease focus: Metabolic diseases Clinical status: Preclinical Founded: March 2002 by Pierre Chambon and Johan Auwerx Corporate partners: NA University collaborators: Institut de Génétique et de Biologie...
BioCentury | Apr 9, 2001
Strategy

The original Gencell gang

The original Gencell gang Applied Immune Sciences Darwin Molecular Group Généthon Genetix Pharmaceuticals Genopoïetic Institut Gustave Roussy Institut Pasteur Lille Introgen Therapeutics Lawrence Berkeley Laboratory Human Gene Center Pasteur Merieux Connaught Transgène Université Louis Pasteur...
BioCentury | Mar 11, 1996
Company News

Universite Louis Pasteur other research news

...of repeats in the FA mutation doesn't correlate with disease severity or age of onset. Universite Louis Pasteur...
BioCentury | Nov 21, 1994
Strategy

How RPR's network creates a complete tool kit

How RPR's network creates a complete tool kit Rhône-Poulenc Rorer Inc.'s gene therapy consortium is designed to create a complete "toolbox" that will give the company the critical mass of technology that currently is dispersed...
Items per page:
1 - 7 of 7